Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia in first salvage-Reference-Cited by-同舟云学术

Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia in first salvage

Published:2019-11-05 Issue:18 Volume:8 Page:7650-7659
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Yoon Jae‐Ho¹^ORCID,Min Gi June¹,Park Sung‐Soo¹,Park Silvia¹,Lee Sung‐Eun¹^ORCID,Cho Byung‐Sik¹^ORCID,Eom Ki‐Seong¹,Kim Yoo‐Jin¹,Kim Hee‐Je¹,Min Chang‐Ki¹,Cho Seok‐Goo¹,Kim Dong‐Wook¹,Lee Jong Wook¹^ORCID,Lee Seok¹

Affiliation:

1. Department of Hematology Catholic Hematology Hospital and Leukemia Research Institute Seoul St. Mary's Hospital College of Medicine The Catholic University of Korea Seoul Korea

Funder

National Research Foundation of Korea

Catholic University of Korea

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2680

Reference40 articles.

1. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

2. Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia